Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction

Journal of the American College of Cardiology

Volumn 33, Issue 3, 1999, Pages 605-611

  García, Eulogio ^a   Elízaga, Jaime ^a   Pérez Castellano, Nicasio ^a   Serrano, Jose A ^a   Soriano, Javier ^a   Abeytua, Manuel ^a   Botas, Javier ^a   Rubio, Rafael ^a   De Sá, Esteban López ^a   López Sendón, Jose L ^a   Delcán, Juan L ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRESSLER SYNDROME; DRUG EFFICACY; EXERCISE TEST; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; DRUG THERAPY, COMBINATION; EXERCISE TEST; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEPARIN; HOSPITAL MORTALITY; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RADIONUCLIDE VENTRICULOGRAPHY; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 0033101682     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00644-5     Document Type: Article

References (30)

1. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-9.
2. Zijlstra F, deBoer MJ, Hoorntje JCA, Reiffers S, Rieber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-4.
3. The global use of strategies to open occluded coronary arteries in acute coronary syndromes (GUSTO lib) angioplasty substudy investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997;336:1621-8.
4. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. JAMA 1997;278:2093-8.
5. Feiring AJ, Johnson MR, Kioschos JM, Kirchner PT, Marcus ML, White CW. The importance of the determination of the myocardial area at risk in the evaluation of the outcome of acute myocardial infarction in patients. Circulation 1987;75:980-7.
6. Thanavaro S, Kleiger RE, Province MA, et al. Effect of infarct location on the in-hospital prognosis of patients with the first transmural myocardial infarction. Circulation 1982;66:742-7.
7. Hands ME, Lloyd BL, Robinson JS, De Klerk N, Thompson PL. Prognostic significance of electrocardiographic site of infarction after correction for enzymatic size of infarction. Circulation 1986;73:885-91.
8. Maisel AS, Gilpin E, Hoit B, et al. Survival after hospital discharge in matched population with inferior or anterior myocardial infarction. J Am Coll Cardiol 1985;6:731-6.
9. Dubois C, Pierard LA, Albert A, et al. Short term risk stratification at admission based on simple clinical data in acute myocardial infarction. Am J Cardiol 1988;61:216-9.
10. Stone PH, Raabe DS, Jaffe AS, et al. Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location. J Am Coll Cardiol 1988;11:453-63.
11. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
12. García E, Elízaga J, Soriano J, et al. Primary angioplasty versus thrombolysis with t-PA in the anterior myocardial infarction [abstract]. J Am Coll Cardiol 1997;29:A-389.
13. Pérez-Castellano N, García EJ, Abeytua M, et al. Influence of collateral circulation on in-hospital death from anterior acute myocardial infarction. J Am Coll Cardiol 1998;31:512-8.
14. Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? Circulation 1995;91:476-85.
15. De Boer MJ, Hoorntje JC, Ottervanger JP, Reiffers S, Suryapranata H, Zijlstra F. Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarc-tion: left ventricular ejection fraction, hospital mortality and reinfarction. J Am Coll Cardiol 1994;23:1004-8.
16. Zijlstra F, de Boer MJ, Ottervanger JP, Liem AL, Hoorntje JC, Suryapranata H. Primary coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: differences in outcome during a mean follow-up of 18 months. Coron Artery Dis 1994;5:707-12.
17. Stone GW, Grines CL, Browne KF, et al. Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy. Am J Cardiol 1996;78:19-25.
18. McGrath PD, Wennberg DE, Malenka DJ, et al. Operator volume and outcomes in 12,988 percutaneous coronary interventions. J Am Coll Cardiol 1998;31:570-6.
19. Gibbons RJ, Holmes DR, Reeder GS, Gailey KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993;328:685-91.
20. Every NR, Parsons LS, Hlatky M, Martin JS, Weaver WD, for the Myocardial Infarction Triage and Intervention Investigators. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. N Engl J Med 1996;335:1253-60.
21. O'Keefe JH Jr, Rutherford BD, McConahay DR, et al. Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1989;64:1221-30.
22. Miller PF, Brodie BR, Weintraub RA, et al. Emergency coronary angioplasty for acute myocardial infarction: results from a community hospital. Arch Intern Med 1987;147:1565-70.
23. Rothbaum DA, Linnemeier TJ, Landin RJ, et al. Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience. J Am Coll Cardiol 1987;10:264-72.
24. Vassanelli C, Ellis SG, Phillips, et al. No greater benefit with PTCA in patients with anterior infarction-updated 30 day result of the GUSTO IIB substudy [abstract]. Circulation 1996;94:I-329.
25. Neuhaus KL, von Essen R, Tebbe U, et al. Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: Results of the rt-PA-APSAC Patency Study (TAPS). J Am Coll Cardiol 1992;19:885-91.
26. Carney RJ, Murphy GA, Brandt TR, et al., for the RAAMI Study Investigators. Randomized angiographic trial of recombinant tissue-type plasminogen activator (Alteplase) in myocardial infarction. J Am Coll Cardiol 1992;20:17-23.
27. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-22.
28. Col NF, Gurwitz JH, Alpert JS, Goldberg RJ. Frequency of inclusion of patients with cardiogenic shock in trials of thrombolytic therapy. Am J Cardiol 1994;73:149-57.
29. Cragg DR, Friedman HZ, Bonema JD, et al. Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy. Ann Intern Med 1991;115:173-7.
30. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.